Explore

🇪🇺 Novartis bets up to $7.8bn on Chinese RNA biotech.

The deal gives it worldwide rights to Abogen’s mRNA-based autoimmune programme ABO2203.

🇪🇺 Novartis is making a major bet on China’s RNA biotech sector.

$575m upfront for Abogen’s ABO2203, with potential payments taking the deal to ~$7.8bn.

Abogen's Strategic Partnership with Novartis for Innovative mRNA Therapeutics #China #Suzhou #Novartis #mRNA_Therapeutics #Abogen

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

🇪🇺 Novartis bets up to $7.8bn on Chinese RNA biotech.

The deal gives it worldwide rights to Abogen’s mRNA-based autoimmune programme ABO2203.

🇪🇺 Novartis is making a major bet on China’s RNA biotech sector.

$575m upfront for Abogen’s ABO2203, with potential payments taking the deal to ~$7.8bn.

Abogen's Strategic Partnership with Novartis for Innovative mRNA Therapeutics #China #Suzhou #Novartis #mRNA_Therapeutics #Abogen